SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-090524
Filing Date
2024-10-25
Accepted
2024-10-25 08:07:42
Documents
17
Period of Report
2024-10-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0218381-8k_elevai.htm   iXBRL 8-K 31851
2 MASTER SERVICES AGREEMENT BETWEEN ELEVAI BIOSCIENCES INC. AND KCRN RESEARCH, INC ea021838101ex10-1_elevai.htm EX-10.1 59957
3 WORK ORDER NUMBER 1 DATED OCTOBER 21, 2024 ea021838101ex10-2_elevai.htm EX-10.2 1805
4 GRAPHIC ex10-2_001.jpg GRAPHIC 316327
5 GRAPHIC ex10-2_002.jpg GRAPHIC 254795
  Complete submission text file 0001213900-24-090524.txt   1070261

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE elab-20241021.xsd EX-101.SCH 3033
7 XBRL LABEL FILE elab-20241021_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE elab-20241021_pre.xml EX-101.PRE 22371
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0218381-8k_elevai_htm.xml XML 3795
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Filer) CIK: 0001840563 (see all company filings)

IRS No.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 241394335
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)